Clinical Trial: A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7x19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma

U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07788118) titled 'A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7x19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma' on Aug. 12.

Brief Summary: This study is aimed to explored the safety and efficacy of 7x19-THEMIS CAR-T cell therapy for large B-cell lymphoma and to conduct an exploratory comparison of the 3-month objective response rate (ORR) and complete remission rate (CR rate) between the experimental cohort and the historical control cohort (NCT04833504).

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Relapsed/Refractory Large B-cell Lymphoma (LBCL) Diffuse Large B-Cell Lymphoma (DLBCL...